Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes

Blood. 2021 Sep 16;138(11):989-992. doi: 10.1182/blood.2021010831.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Mutation
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / genetics*
  • Phosphoproteins / genetics*
  • Prognosis
  • RNA Splicing Factors / genetics*
  • Survival Analysis

Substances

  • Phosphoproteins
  • RNA Splicing Factors
  • SF3B1 protein, human